A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
People gathered in Manchester Piccadilly Gardens to demonstrate their anger towards the refugee crisis.
Settling down this weekend as high pressure builds
Former Manchester United manager Sir Alex Ferguson has told ITV Sport he twice failed to sign Wayne Rooney before finally getting his man.